Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05721677

CLABSI Prevention With Tissue Adhesive

Conditions: Central-line Associated Blood Stream Infections (CLABSI)

Sex: All
Ages: 0 Days – 18 Years
Phase: NA
Enrollment: 600
Sponsor: Rabin Medical Center

Summary

Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.

Eligibility Criteria

Inclusion Criteria:All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):young age<1yweight ≤5 kgRisk Adjustment for Congenital Heart Surgery (RACHS) category ≥3STS-EACTS Congenital Heart Surgery Mortality Category (STAT) score 3-5preoperative length-of-stay (LOS) >1 daypreoperative ventilator supportpresence of a genetic abnormalitypre-operative blood product exposureextracorporeal membrane oxygenation (ECMO) supportExclusion Criteria:Patients with on-going bacteremiapatients with pre-existing central-line or peripherally inserted central catheter (PICC)parental refusal to participate.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05721677). StuddyBuddy aggregates publicly available trial information.